HC Wainwright began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research report released on Monday, MarketBeat reports. The firm issued a buy rating and a $9.00 target price on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings […]
HC Wainwright assumed coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a report released on Monday, MarketBeat reports. The brokerage issued a buy rating and a $9.00 price target on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings at […]
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,. | April 3, 2023